Experimental Hematology
Volume 34, Issue 7 , Pages 914-925, July 2006

Early appearance of stem/progenitor cells with neural-like characteristics in human cord blood mononuclear fraction cultured in vitro

  • Aleksandra Habich

      Affiliations

    • NeuroRepair Department, Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
  • ,
  • Marcin Jurga

      Affiliations

    • NeuroRepair Department, Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
  • ,
  • Inga Markiewicz

      Affiliations

    • NeuroRepair Department, Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
  • ,
  • Barbara Lukomska

      Affiliations

    • NeuroRepair Department, Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
  • ,
  • Urszula Bany-Laszewicz

      Affiliations

    • Department of Biochemistry, Institute of Hematology and Blood Transfusion, Warsaw, Poland
  • ,
  • Krystyna Domanska-Janik

      Affiliations

    • NeuroRepair Department, Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
    • Corresponding Author InformationOffprint requests to: Krystyna Domańska-Janik, M.D., Ph.D., D.Sc., NeuroRepair Department, Medical Research Center, Polish Academy of Sciences, 5, Pawinskiego str, 02 106 Warsaw, Poland

Received 5 December 2005; received in revised form 20 March 2006; accepted 20 March 2006.

Objective

The exposure of human umbilical cord blood mononuclear cells devoid of hematopoietic stem cells (HUCB-MNCsCD34-) to defined culture condition promotes their conversion into neural lineage. We have asked the question if observed fate change of HUCB-MNCsCD34- results from direct conversion of hematopoietic precursors into neural-like phenotypes due to expression of overlapping genetic program or, alternatively, these neural phenotypes arise from sequential differentiation of more primitive progenitors (embryonic-like cells) preexisting in HUCB-MNCsCD34- fraction.

Materials and Methods

HUCB-MNCs negatively selected for CD34 antigens were cultured in vitro up to 14 days. Changes in stem/neural cell genes and proteins were successively evaluated during this period and after evoked neuronal differentiation of cells in the presence of RA or BDNF or cocultured with neonatal rat brain astrocytes.

Results

Freshly isolated HUCB-MNCsCD34- expressed pluripotent cell markers: Oct3/4, Sox2, and Rex1 genes. During 24 hours of culture the frequency of Oct3/4 immunopositive cells increased markedly with parallel enlargement of “side population” and CD133+ cell appearance. Concomitantly, cultured cells start to form aggregates and express pro-neural genes, i.e., enhanced Sox2, OTX1, Nestin, GFAP, and NF-200. During the next days of culture immunoreactions for β-tubulin III, MAP2, GFAP, S100β, Doublecortin, and GalC were induced with reciprocal lowering of stem cell gene and protein markers. At this stage cells successively adhered to the bottom, dispersed, and decreased proliferation rate (Ki67 expression). Additional treatments with neuromorphogenes or coculturing with rat brain primary culture induced further differentiation of these neural precursors toward more advanced neuronal phenotypes.

Conclusions

HUCB-MNCsCD34- fraction contains embryonic-like stem/progenitor cells which increase rapidly but transiently in culture, then differentiate spontaneously after cell aggregate adhesion toward neural lineage. Neurally promoted cells from 10-14 DIV culture acquire three main neural-like phenotypes, i.e., neurons, astrocytes, and oligodendrocytes. In this respect they are promising candidates for experimental treatment of neuronal injury; however, the final proof for conversion of HUCB cells to neural cells can be obtained through transplantation experiments.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(06)00197-4

doi:10.1016/j.exphem.2006.03.010

Experimental Hematology
Volume 34, Issue 7 , Pages 914-925, July 2006